Alvotech
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ALVOW | BIIB | ALDX | 6IB.F | ALNY | ROIV | |
|---|---|---|---|---|---|---|
| Market cap | — | 37.61B | 39.06M | 17.27B | 21.57B | 27.61B |
| P/E (TTM) | — | 110.2 | — | 123.8 | 8.1 | — |
| Forward P/E | — | 15.6 | -2.4 | — | 14.4 | -27.5 |
| Price/book | -0.3 | 2.0 | 1.0 | 6.2 | 6.0 | 6.5 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | — | +62.35% | −87.40% | −1.76% | −63.43% | +85.85% |
| Today | −6.73% | +2.22% | +4.32% | +3.42% | +0.74% | +6.08% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All ALVOW news ›Alvotech: The Market Is Still Pricing The Broken Factory
Alvotech Stock: The Market Is Still Pricing The Broken Factory (NASDAQ:ALVO) Seeking Alpha - Alvotech is transitioning from supply remediation to throughput, with FDA-cleared facilities and multiple key biosimilar filings advancing toward…
Alvotech (NASDAQ:ALVO) & Valion Bio, Inc. Common Stock (NASDAQ:VBIO) Head to Head Survey
Posted by Defense World Staff on Oct 26th, 2026 Alvotech (NASDAQ:ALVO – Get Free Report) and Valion Bio, Inc. Common Stock (NASDAQ:VBIO – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will…
Alvotech (NASDAQ:ALVO) Upgraded to “Hold” at Wall Street Zen
Posted by Mitch Edgeman on Oct 25th, 2026 Wall Street Zen upgraded shares of Alvotech (NASDAQ:ALVO – Free Report) from a sell rating to a hold rating in a report published on Saturday,Wall Street Zen reports. Check Out Our Latest Stock…
Alvotech wins FDA approval to more than double SIMLANDI batch output
The Oct. 20 announcement says the process frees capacity for other biosimilars but gives no implementation date or quantified unit-cost savings. More than twice as much SIMLANDI drug substance can be produced per batch after Alvotech…
Alvotech: SIMLANDI output per batch more than doubles
Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania Fort Technology: Logia USA Signs Exclusive Distribution Agreement to Expand Fuel Maintenance Solutions for Data…
Alvotech And Advanz Pharma Holdco Limited Submit European Regulatory Application For AVT29, Proposed Biosimilar To Eylea 8 Mg
Alvotech and Advanz Pharma announced the submission of a European regulatory application for AVT29, a proposed biosimilar to Eylea® 8 mg , which is marketed as Eylea HD® in the United States. Based... Alvotech and Advanz Pharma announced…
Alvotech Announces FDA Approval of New Manufacturing Process for SIMLANDI Biosimilar to Increase Drug Substance Output
Alvotech announces FDA approval of a new manufacturing process for SIMLANDI®, enhancing production efficiency while maintaining quality. Alvotech received FDA approval for a new manufacturing process for its biosimilar SIMLANDI®…
Alvotech, Advanz seek EU nod for high-dose Eylea biosimilar
Alvotech and Advanz Pharma submitted a regulatory application for AVT29, a proposed biosimilar to Eylea 8 mg, in Europe, Alvotech said Wednesday. Alvotech said the application was submitted as a... Biotechnology & Medical Research…
Alvotech Wins US FDA Nod for New Humira Biosimilar Manufacturing Process
marketscreener.com Biotechnology & Medical Research Alvotech Wins US FDA Nod for New Humira Biosimilar Manufacturing Process Published on 10/20/2026 at 05:38 am EDT
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com8
- stocktitan.net8
- quiverquant.com5
- globenewswire.com4
- manilatimes.net4
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 60 articles, not a forecast.